Logo image
Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions
Journal article   Open access   Peer reviewed

Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions

C C Silliman, Yoke Lin Fung, J Bradley Ball and S Y Khan
Blood Reviews, Vol.23(6), pp.245-255
2009
pdf
PDF - Author's Accepted Version (Open Access)726.57 kBDownloadView
Accepted VersionPDF - Author Accepted Version (Open Access)CC BY-NC-ND V4.0 Open Access
url
https://doi.org/10.1016/j.blre.2009.07.005View
Published Version

Abstract

neutrophils priming two event model antibodies lipids
Transfusion-related acute lung injury (TRALI) is the most common cause of serious morbidity and mortality due to hemotherapy. Although the pathogenesis has been related to the infusion of donor antibodies into the recipient, antibody negative TRALI has been reported. Changes in transfusion practices, especially the use of male-only plasma, have decreased the number of antibody-mediated cases and deaths; however, TRALI still occurs. The neutrophil appears to be the effector cell in TRALI and the pathophysiology is centered on neutrophil-mediated endothelial cell cytotoxicity resulting in capillary leak and ALI. This review will detail the pathophysiology of TRALI including recent pre-clinical data, provide insight into newer areas of research, and critically assess current practices to decrease it prevalence and to make transfusion safer. © 2009 Elsevier Ltd. All rights reserved.

Details

Metrics

16 File views/ downloads
511 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Hematology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image